CANCER-CHEMOTHERAPY - CONGENER SYNTHESIS

被引：14

作者：

MONTGOMERY, JA

机构：

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1980年 / 23卷 / 10期

关键词：

D O I：

10.1021/jm00184a001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1063 / 1067

页数：5

共 58 条

[1]

ALBERT A, 1960, SELECTIVE TOXICITY, P31

[2]

Baker BR, 1967, DESIGN ACTIVE SITE D

[3] ACTIVITY AND MECHANISM OF ACTION OF 6-METHYLTHIOPURINE RIBONUCLEOSIDE IN CANCER CELLS RESISTANT TO 6-MERCAPTOPURINE [J].

BENNETT, LL ;

BROCKMAN, RW ;

SCHNEBLI, HP ;

CHUMLEY, S ;

DIXON, GJ ;

SCHABEL, FM ;

DULMADGE, EA ;

SKIPPER, HE ;

MONTGOMERY, JA ;

THOMAS, HJ .

NATURE, 1965, 205 (4978) :1276-+

[4]

BERTINO JR, 1965, CANCER RES, V25, P1614

[5]

BODEY GP, 1968, CANCER CHEMOTH REP, V52, P315

[6] BIOLOGIC ACTIVITY OF 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE - METABOLICALLY STABLE ANALOG OF 9-BETA-D-ARABINOFURANOSYLADENINE [J].

BROCKMAN, RW ;

SCHABEL, FM ;

MONTGOMERY, JA .

BIOCHEMICAL PHARMACOLOGY, 1977, 26 (22) :2193-2196

[7]

BROCKMAN RW, 1978, CURRENT CHEMOTHERAPY, V1, P97

[8]

BROCKMAN RW, 1975, ANNU S FUNDAMENTAL C, V27, P691

[9]

BRUNDRETT RB, 1976, P AM ASSOC CANC RES, V17, P102

[10]

BUDESINSKY Z, 1962, COLLECT CZECH CHEM C, V27, P2550

← 1 2 3 4 5 6 →